| 000 | 00769 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513210636.0 | ||
| 264 | 0 | _c20000504 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOffit, P A | |
| 245 | 0 | 0 |
_aPreventing harm from thimerosal in vaccines. _h[electronic resource] |
| 260 |
_bJAMA _cApr 2000 |
||
| 300 |
_a2104; author reply 2105 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aPreservatives, Pharmaceutical _xadverse effects |
| 650 | 0 | 4 |
_aThimerosal _xadverse effects |
| 650 | 0 | 4 |
_aVaccination _xstandards |
| 650 | 0 | 4 |
_aVaccines _xadverse effects |
| 773 | 0 |
_tJAMA _gvol. 283 _gno. 16 _gp. 2104; author reply 2105 |
|
| 999 |
_c10743822 _d10743822 |
||